Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Yoshimoto, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    2. Murata, T; Yamawaki, H; Yoshimoto, R; Hori, M; Sato, K; Ozaki, H; Karaki, H
      Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study

      LIFE SCIENCES
    3. Takahara, A; Hirasawa, A; Dohmoto, H; Shoji, M; Yoshimoto, R; Sugiyama, A; Hashimoto, K
      In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models

      JAPANESE JOURNAL OF PHARMACOLOGY
    4. Takahara, A; Dohmoto, H; Yoshimoto, R; Sugiyama, A; Hashimoto, K
      Utilization of telemetry system to assess the cardiovascular profile of AH-1058, a mew cardioselective Ca2+ channel blocker, in conscious dogs

      JAPANESE JOURNAL OF PHARMACOLOGY
    5. Takahara, A; Dohmoto, H; Yoshimoto, R; Sugiyama, A; Hashimoto, K
      Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Konda, T; Takahara, A; Maeda, K; Dohmoto, H; Yoshimoto, R
      Effects of a dual L/N-type Ca2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Kageyama, S; Yamamoto, H; Yoshimoto, R
      Anti-human von willebrand factor monoclonal antibody AJvW3 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    8. Gong, HB; Rashid, M; Nakamura, T; Hattori, K; Nakazawa, M; Kihara, H; Yoshimoto, R; Nagatomo, T
      Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylserotonin: Comparison with ketanserin

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    9. Takahara, A; Sugiyama, A; Dohmoto, H; Yoshimoto, R; Hashimoto, K
      Comparison of cardiovascular effects of a new calcium channel blocker AH-1058 with those of verapamil assessed in blood-perfused canine heart preparations

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    10. Kihara, H; Hirose, K; Koganei, H; Sasaki, N; Yamamoto, H; Kimura, A; Nishimori, T; Shoji, M; Yoshimoto, R
      AT-1015, a novel serotonin (5-HT)(2) receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    11. Yoshimoto, R; Hori, M; Ozaki, H; Karaki, H
      Proteolysis of acidic calponin by mu-calpain

      JOURNAL OF BIOCHEMISTRY
    12. Yoshimoto, R; Hori, M; Takahashi, K; Taniguchi, S; Katsuki, M; Ozaki, H; Karaki, H
      Ca2+-sensitization of contraction in the h1 calponin-deficient smooth muscle

      JAPANESE JOURNAL OF PHARMACOLOGY
    13. Takahara, A; Sugiyama, A; Dohmoto, H; Yoshimoto, R; Hashimoto, K
      Electrophysiological and cardiohemodynamic effects of AH-1058, a new type calcium channel blocker, assessed by the in vivo canine model

      JAPANESE JOURNAL OF PHARMACOLOGY
    14. Takahara, A; Sugiyama, A; Dohmoto, H; Yoshimoto, R; Hashimoto, K
      Antiarrhythmic and cardiohemodynamic effects of a novel Ca2+ channel blocker, AH-1058, assessed in canine arrhythmia models

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Takahashi, K; Yoshimoto, R; Fuchibe, K; Fujishige, A; Mitsu-Saito, M; Hori, M; Ozaki, H; Yamamura, H; Awata, N; Taniguchi, S; Katsuki, M; Tsuchiya, T; Karaki, H
      Regulation of shortening velocity by calponin in intact contracting smoothmuscles

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    16. Uneyama, H; Takahara, A; Wakamori, M; Mori, Y; Yoshimoto, R
      Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    17. Eto, K; Isshiki, T; Yamamoto, H; Takeshita, S; Ochiai, M; Yokoyama, N; Yoshimoto, R; Ikeda, Y; Sato, T
      AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    18. Takahara, A; Uneyama, H; Sasaki, N; Ueda, H; Dohmoto, H; Shoji, M; Hara, Y; Nakaya, H; Yoshimoto, R
      Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmiasand cardiac membrane currents

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    19. Mori, K; Imamaki, A; Nagata, K; Yonetomi, Y; Kiyokage-Yoshimoto, R; Martin, TJ; Gillespie, MT; Nagahama, M; Tsuji, A; Matsuda, Y
      Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells

      JOURNAL OF BIOCHEMISTRY
    20. Uneyama, H; Uchida, H; Konda, T; Yoshimoto, R; Akaike, N
      Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. YAMAMOTO H; VREYS I; STASSEN JM; YOSHIMOTO R; VERMYLEN J; HOYLAERTS MF
      ANTAGONISM OF VWF INHIBITS BOTH INJURY-INDUCED ARTERIAL AND VENOUS THROMBOSIS IN THE HAMSTER

      Thrombosis and haemostasis
    22. UCHIDA H; UNEYAMA H; YOSHIMOTO R; KOIZUMI S; UENO S; INOUE K
      A DIHYDROPYRIDINE COMPOUND, CILNIDIPINE, STRONGLY BLOCKED THE CATECHOLAMINE SECRETION FROM THE DIFFERENTIATED RAT PC12 CELLS

      Journal of hypertension
    23. UNEYAMA H; TAKAHARA A; YOSHIMOTO R; AKAIKE N
      SELECTIVITIES OF A L-TYPE AND N-TYPE CA2+ CHANNEL DUAL ANTAGONIST, CILNIDIPINE, FOR THE CARDIAC AND THE SYMPATHETIC CA2+ CHANNEL CURRENTS

      Journal of hypertension
    24. UNEYAMA H; UCHIDA H; YOSHIMOTO R; UENO S; INOUE K; AKAIKE N
      EFFECTS OF A NOVEL ANTIHYPERTENSIVE DRUG, CILNIDIPINE, ON CATECHOLAMINE SECRETION FROM DIFFERENTIATED PC12 CELLS

      Hypertension
    25. KIHARA H; KOGANEI H; YAMAMOTO H; HIROSE K; SHOJI M; YOSHIMOTO R
      AT-1015, A NOVEL LONG-ACTING SEROTONIN (5-HT)(2A) RECEPTOR ANTAGONIST, PREVENTS ARTERIAL THROMBUS FORMATION WITHOUT PROLONGATION OF BLEEDING-TIME IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    26. ETO K; ISSHIKI T; TAKESHITA S; OCHIAI M; SATO T; YAMAMOTO H; YOSHIMOTO R
      VON-WILLEBRAND FACTOR-DEPENDENT PLATELET-AGGREGATION IS ENHANCED DURING CHEST PAIN ATTACKS IN PATIENTS WITH UNSTABLE ANGINA - EFFECT OF AJVW-2, ANTI-VWF A1 DOMAIN ANTIBODY AGAINST UNSTABLE ANGINA

      Circulation
    27. ETO K; ISSHIKI T; OCHIAI M; TAKESHITA S; MITANI H; TOKUDA T; SATO T; YAMAMOTO H; YOSHIMOTO R
      EFFECT OF AJVW-2, ANTI-HUMAN VON-WILLEBRAND-FACTOR (VWF) A1 DOMAIN MOAB, ON VWF-DEPENDENT PLATELET-AGGREGATION FOLLOWING CORONARY STENT IMPLANTATION

      Circulation
    28. YOSHIMOTO R; MITSUISAITO M; OZAKI H; KARAKI H
      EFFECTS OF ADRENOMEDULLIN AND CALCITONIN-GENE-RELATED PEPTIDE ON CONTRACTIONS OF THE RAT AORTA AND PORCINE CORONARY-ARTERY

      British Journal of Pharmacology
    29. Uneyama, H; Uchida, H; Maeda, K; Yoshimoto, R; Watanabe, Y; Inoue, K
      Non-L-type actions of organic Ca2+ channel blockers: Implications for Na+ and N-type Ca2+ channels blockades

      CALCIUM ION MODULATORS
    30. KUBUKI M; YOSHIMOTO R; YOSHIZUMI K; TSURU S; HARA M
      ESTIMATION OF DC BREAKDOWN MECHANISMS IN AIR GAPS CONTAINING FLOATINGMETALLIC PARTICLES

      IEEE transactions on dielectrics and electrical insulation
    31. TAKAHARA A; DOHMOTO H; HISA H; SATOH S; YOSHIMOTO R
      CILNIDIPINE ATTENUATES RENAL NERVE STIMULATION-INDUCED RENAL VASOCONSTRICTION AND ANTINATRIURESIS IN ANESTHETIZED DOGS

      Japanese Journal of Pharmacology
    32. ETO K; ISSHIKI T; NISHIYAMA Y; YAMAMOTO H; YOSHIMOTO R; TAKESHITA S; OCHIAI M; SATO T
      ANTI-VON-WILLEBRAND-FACTOR A1 DOMAIN MOAB, AJVW-2, INHIBITS HIGH-SHEAR STRESS-INDUCED PLATELET-AGGREGATION ACCELERATED IN ACUTE MYOCARDIAL-INFARCTION

      Circulation
    33. UNEYAMA H; TAKAHARA A; DOHMOTO H; YOSHIMOTO R; INOUE K; AKAIKE N
      BLOCKADE OF N-TYPE CA2-8653) IS ACUTELY DISSOCIATED RAT SYMPATHETIC NEURONS( CURRENT BY CILNIDIPINE (FRC)

      British Journal of Pharmacology
    34. KAGEYAMA S; YAMAMOTO H; NAGANO M; ARISAKA H; KAYAHARA T; YOSHIMOTO R
      ANTITHROMBOTIC EFFECTS AND BLEEDING RISK OF AJVW-2, A MONOCLONAL-ANTIBODY AGAINST HUMAN VON-WILLEBRAND-FACTOR

      British Journal of Pharmacology
    35. FUKUCHI N; YAMAMOTO H; KITO M; TANAKA A; KAYAHA T; NAGANO; ISHII K; KOBAYASHI T; YOSHIMOTO R
      AS1051, THE ALPHA-CHAIN DERIVATIVE OF SNAKE PROTEIN, PREVENTED THROMBUS FORMATION BY SP GPIB ANTAGONISM WITHOUT INDUCING THR CYTOPENIA

      Blood
    36. KUBUKI M; YOSHIMOTO R; TANOUE K; HARA M
      BREAKDOWN CHARACTERISTICS IN AIR GAPS WITH ARTIFICIAL FLOATING METALSUNDER DC VOLTAGE

      IEEE transactions on dielectrics and electrical insulation
    37. YAMAMOTO H; NAGANO M; KITOH M; KOBAYASHI T; YOSHIMOTO R
      MONOCLONAL-ANTIBODY AGAINST VON-WILLEBRAND-FACTOR INHIBITS THROMBUS FORMATION WITHOUT PROLONGATION OF BLEEDING-TIME

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 13:56:01